Physician

Odalys Frontela, M.D.

According to 2025 Medicare claims, Odalys Frontela, M.D. (NPI: 1639102700) practices general practice in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is FUTURE ENLIGHTMENT CORP (NPI: 1790505469; TIN: 331262973) and primary practice location at 33186-7298. Frontela is affiliated with the Sound Physicians Long Term Care Managment II (ACO ID: A5538), participating under the MSSP model.

Frontela's data goes back to 2015 and runs through 2024. Part D data shows 1,593 prescription claims across 165 beneficiaries totaling $145,022 in drug costs, led by Eliquis (Apixaban). DME data shows 22 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $70,849 to $145,022. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$83K$166K2015 Drug cost: $70,849 (USD; Tot_Drug_Cst)2016 Drug cost: $30,829 (USD; Tot_Drug_Cst)2017 Drug cost: $23,888 (USD; Tot_Drug_Cst)2018 Drug cost: $51,305 (USD; Tot_Drug_Cst)2019 Drug cost: $100,176 (USD; Tot_Drug_Cst)2020 Drug cost: $97,023 (USD; Tot_Drug_Cst)2021 Drug cost: $112,817 (USD; Tot_Drug_Cst)2022 Drug cost: $148,262 (USD; Tot_Drug_Cst)2023 Drug cost: $166,104 (USD; Tot_Drug_Cst)2024 Drug cost: $145,022 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015921,242$70,849
2016931,198$30,829
201730834$23,888
2018123961$51,305
20191411,340$100,176
20201581,504$97,023
20211601,527$112,817
20221691,550$148,262
20231721,590$166,104
20241651,593$145,022

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.6K$3.2K2017 Medicare payment: $2,687 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,250 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,392 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,358 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,652 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R42$2,687
2018N/R52$3,250
2019N/R24$1,392
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R26$2,358
2023N/RN/RN/R
2024N/R22$2,652

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban512,430$46,527
EntrestoSacubitril/Valsartan12540$12,124
OzempicSemaglutide13490$11,459
FarxigaDapagliflozin Propanediol18540$10,144
RamelteonRamelteon19570$1,804

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
B4150Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unitNN/R11$1,680
B4034Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tapeNN/R11$973

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Odalys Frontela, M.D.?

Tedicare shows public-source Medicare data for Odalys Frontela, M.D. (NPI 1639102700), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Odalys Frontela, M.D. have ACO affiliation data?

Odalys Frontela, M.D. is shown with ACO affiliation data for Sound Physicians Long Term Care Managment II (MSSP, ACO ID A5538).

What billing organization is linked to Odalys Frontela, M.D.?

Odalys Frontela, M.D. is linked to FUTURE ENLIGHTMENT CORP (billing NPI 1790505469) in the available physician profile data.

Does Odalys Frontela, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.